Jobs / United States / Iovance Biotherapeutics INC

Iovance Biotherapeutics INC

AI Strategist, Clinical & R&D

Remote · Remote · region not stated Posted 4 days ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Where you can work from

Location not specified

The listing does not say where you can work from. Missing information is not the same as worldwide: check before applying.

The company's headquarters is not the same as where you may work from. Visa sponsorship only matters if you would relocate; see below.

Visa sponsorship, if you would relocate

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview Iovance Biotherapeutics is a commercial-stage cell therapy company focused on developing life-saving cancer immunotherapies. We are building an internal AI Strategy & Operations function to drive measurable cost savings and operational efficiency across every department in the company. Iovance seeks an AI Strategist to lead AI strategy for Iovance’s Clinical Development, Research, Regulatory Affairs, Drug Safety, and Medical Writing organizations. Much of the work in these functions already runs on established enterprise platforms. Your job is to make those platforms deliver measurable value, and to find the places where a targeted build is worth it. You will be the AI program’s embedded strategist for these functions. You will learn how the work gets done, find the problems worth solving, build the first working prototype where one is needed, and hand it to a shared engineering team to take to production. In this role, you will own the outcomes, not just the recommendation. The successful candidate is required to be adept at using AI tools, be able to identify AI solutions, and build working prototypes that engineering can take to production. Essential Functions and Responsibilities • Serve as the embedded AI strategist for Clinical Development, Research, Regulatory Affairs, Drug Safety, and Medical Writing. Build working relationships with function leaders and act as the AI program’s primary point of contact for those teams. • Conduct structured stakeholder interviews to map business processes end to end and identify AI-addressable pain points. Document use cases with enough detail for technical teams to build from. • Build working prototypes using AI tools (Claude, Cursor, or similar) to validate use cases with stakeholders. You do not need to be a developer, but you are expected to build prototypes that work, not mockups. Your prototype is the starting point for engineering. • Prepare the handoff for every use case that enters the build queue: user workflow, success metrics, data sources, integration requirements, GxP classification, and savings methodology. • Score and rank use cases against savings and revenue levers, implementation feasibility, and time-to-value. Enforce the gate: no P&L mapping and no named business sponsor means no prioritization. • Drive adoption of the enterprise platforms these functio

Apply on employer site ↗